Join Growin Stock Community!

Apollomics, inc.APLMW.US Overview

US StockHealthcare
(No presentation for APLMW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

APLMW AI Insights

APLMW Overall Performance

APLMW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

APLMW Recent Performance

-

Apollomics, inc.

0.05%

Avg of Sector

-0.31%

S&P500

APLMW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

APLMW Key Information

APLMW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

APLMW Profile

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.

Price of APLMW

APLMW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

APLMW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1

No related data records

  • When is APLMW's latest earnings report released?

    The most recent financial report for Apollomics, inc. (APLMW) covers the period of 2024Q2 and was published on 2024/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating APLMW's short-term business performance and financial health. For the latest updates on APLMW's earnings releases, visit this page regularly.

  • What is the operating profit of APLMW?

    According to the latest financial report, Apollomics, inc. (APLMW) reported an Operating Profit of -12.57M with an Operating Margin of -1,299.43% this period, representing a growth of 2.09% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is APLMW's revenue growth?

    In the latest financial report, Apollomics, inc. (APLMW) announced revenue of 967.5K, with a Year-Over-Year growth rate of 296.52%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does APLMW have?

    At the end of the period, Apollomics, inc. (APLMW) held Total Cash and Cash Equivalents of 9.77M, accounting for 0.75 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is APLMW's EPS continuing to grow?

    According to the past four quarterly reports, Apollomics, inc. (APLMW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.19. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of APLMW?

    Apollomics, inc. (APLMW)'s Free Cash Flow (FCF) for the period is -8.01M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 34.39% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.